Status: Not yet recruiting
Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women
Evaluation of the Excretion of Fosfomycin into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women
Participants needed: 24
Trial details
Phase: Phase 4Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Meitheal Pharmaceuticals, Inc.Updated: Jun 1, 2026
Eligibility criteria
Participant must be 18 to 45 years of age inclusive, at the time of signing the... [+9]
Participant is pregnant or plans to become pregnant during the course of the stu... [+16]